SCHEMBL4447774

SCHEMBL4447774

CCCc1cc(Cl)nc(SC)n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.45
POLB P06746 1/20 0.45
KMT2A Q03164 5/20 0.41
MEN1 O00255 2/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
MAPT P10636 3/20 0.37
CYP1A2 P05177 1/20 0.36
BACE1 P56817 1/20 0.35
HPGD P15428 1/20 0.35
KDM4E B2RXH2 2/20 0.34
KDM5B Q9UGL1 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TP53 P04637 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462899 0.85 HTT (0.47) HTTPOLBKMT2AMEN1GAA
SCHEMBL7015906 0.84 CYP1A2 (0.45) POLBKMT2AMEN1NOS3NOS1
SCHEMBL10845926 0.82 POLB (0.49) HTTPOLBKMT2AMEN1GAA
SCHEMBL3943057 0.80 POLB (0.41) HTTPOLBKMT2AMEN1GAA
SCHEMBL14399610 0.79 POLB (0.46) HTTPOLBKMT2AMEN1GAA
SCHEMBL4444475 0.78 BACE1 (0.39) GAASMN1; SMN2NOS3NOS1NOS2
SCHEMBL62021 0.77 POLB (0.53) HTTPOLBKMT2AMEN1GAA
SCHEMBL11834300 0.77 CTSK (0.40) KMT2AMEN1CYP1A2HPGDKDM4E
SCHEMBL5672114 0.76 NOS3 (0.42) HTTPOLBKMT2ANOS3NOS1
SCHEMBL10846214 0.75 KMT2A (0.53) HTTKMT2AMEN1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118164965-A Pyrimidine-triazole-fluorine substituted phenyl cyclopropylamine derivative and application thereof 郑州大学 2024-06-11 CN disclosed
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US disclosed
EP-1758870-B1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2008-08-13 EP disclosed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US disclosed
EP-1758870-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2007-03-07 EP disclosed
WO-2005121106-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives P2RY4, P2RX4, P2RY1 HTT 3019/4885POLB 696/4885KMT2A 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.